Results 11 to 20 of about 11,094 (264)
Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020 [PDF]
Endocrinology and Metabolism, 2021 Over the last two decades, our understanding of diabetes and treatment strategies have evolved tremendously, from scientific, mechanistic, and human perspectives.
Eun-Jung Rhee +2 more
doaj +1 more source
Lipid profile of Mexican children with Down syndrome
BMC Pediatrics, 2021 Introduction Down syndrome (DS) is associated with various congenital anomalies and metabolic alterations, such as dyslipidemias, that can lead to cardiovascular disease in adulthood.
Silvestre Garcia-de la Puente +3 more
doaj +1 more source
Treatment of dyslipidemia [PDF]
F1000Prime Reports, 2014 Atherosclerotic cardiovascular disease (including coronary heart disease, stroke and peripheral arterial disease) is the leading cause of death globally. Abnormal blood lipids (dyslipidemia), smoking, and high blood pressure are responsible for more than 75% of cases.
Tonkin, Andrew, Byrnes, Allison
openaire +2 more sources
Сахарный диабет, 2004 Cardiovascular diseases (CVD) are responsible for 75% of the morbidity and mortality in patients with type 2 diabetes. Diabetes accelerates plaque formation and progression in coronary, cerebrovascular and peripheral arteries.
HELENA W RODBARD
doaj +1 more source
Arquivos Brasileiros de Cardiologia, 2016 Lipoproteins constitute a set of proteins and lipids, organized to facilitate the transport of lipids through blood plasma. Elevated or decreased levels of these lipoproteins may be related to genetic alterations in 40% to 60% of cases.1 This fact explains why it is common to find lipid abnormalities in several members of the same family.
García-Giustiniani, Diego +1 more
openaire +4 more sources
Indian Journal of Endocrinology and Metabolism, 2013 Atherogenic dyslipidemia (AD) refers to elevated levels of triglycerides (TG) and small-dense low-density lipoprotein and low levels of high-density lipoprotein cholesterol (HDL-C). In addition, elevated levels of large TG rich very low-density lipoproteins, apolipoprotein B and oxidised low-density lipoprotein (LDL), and reduced ...
C N Manjunath +3 more
openaire +3 more sources
The Journal of Clinical Endocrinology & Metabolism, 2007 Recently, considerable progress has been made in understanding the genetic basis of dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs for coronary heart disease (CHD) prevention. Novel loci have been identified for monogenic hypercholesterolemia, such as low-density lipoprotein (LDL) receptor (LDLR)-associated protein ...
Abhimanyu, Garg, Vinaya, Simha
openaire +2 more sources
ChildrenFamilial hypercholesterolemia (FH) is a common genetic disorder with a fairly constant worldwide prevalence of 1 case per 311 individuals worldwide.
Maria Elena Capra +5 more
doaj +1 more source
Evaluation of Lipid Profiles of Children and Youth from Basic Health Units in Campinas, SP, Brazil: A Cross-Sectional Laboratory Study [PDF]
Arquivos Brasileiros de CardiologiaBackground: Among dyslipidemias, hypercholesterolemia is considered the main risk factor for cardiovascular diseases in adults. In childhood and adolescence, elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) are positively ...
Érica Ivana Lázaro Gomes +2 more
doaj +3 more sources
Plant Sterols and Stanols for Pediatric Patients with Increased Cardiovascular Risk
ChildrenThe atherosclerotic process begins in childhood and progresses throughout adult age. Hypercholesterolemia, especially familial hypercholesterolemia (FH) and metabolic dysfunctions linked to weight excess and obesity, are the main atherosclerosis risk ...
Cristina Pederiva +3 more
doaj +1 more source